ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC16975-1mg |
|
204326-43-2 |
NS 2028
|
0 | C9H5BrN2O3 | |
GC16974-50mg |
|
115-79-7 |
Ambenonium dichloride
|
0 | C28H42Cl4N4O2 | |
GC16974-10mg |
|
115-79-7 |
Ambenonium dichloride
|
0 | C28H42Cl4N4O2 | |
GC16973-10mM (in 1mL DMSO) |
|
89464-63-1 |
DMOG
|
0 | C6H9NO5 | |
GC16973-200mg |
|
89464-63-1 |
DMOG
|
0 | C6H9NO5 | |
GC16973-100mg |
|
89464-63-1 |
DMOG
|
0 | C6H9NO5 | |
GC16973-50mg |
|
89464-63-1 |
DMOG
|
0 | C6H9NO5 | |
GC16972-10mM (in 1mL DMSO) |
|
1185763-69-2 |
NVP-BVU972
|
0 | C20H16N6 | |
GC16972-5mg |
|
1185763-69-2 |
NVP-BVU972
|
0 | C20H16N6 | |
GC16972-50mg |
|
1185763-69-2 |
NVP-BVU972
|
0 | C20H16N6 | |
GC16972-10mg |
|
1185763-69-2 |
NVP-BVU972
|
0 | C20H16N6 | |
GC16971-500mg |
|
1094-61-7 |
beta-Nicotinamide mononucleotide
|
0 | C11H16N2O8P | |
GC16971-100mg |
|
1094-61-7 |
beta-Nicotinamide mononucleotide
|
0 | C11H16N2O8P | |
GC16970-10mM (in 1mL DMSO) |
|
80621-81-4 |
Rifaximin (Xifaxan)
|
0 | C43H51N3O11 | |
GC16970-1g |
|
80621-81-4 |
Rifaximin (Xifaxan)
|
0 | C43H51N3O11 | |
GC16970-500mg |
|
80621-81-4 |
Rifaximin (Xifaxan)
|
0 | C43H51N3O11 | |
GC16969-1mg |
|
62340-29-8 |
Oxyntomodulin
|
0 | C192H295N59O60S | |
GC16967-25mg |
|
— |
Cy7 NHS ester
|
0 | C41H46N3NaO10S2 | |
GC16967-5mg |
|
— |
Cy7 NHS ester
|
0 | C41H46N3NaO10S2 | |
GC16966-10mM (in 1mL DMSO) |
|
1134156-31-2 |
VER 155008
|
0 | C25H23Cl2N7O4 | |